版本:
中国

BRIEF-U.S. FDA approves Spectral's third PMA module for its toraymyxin treatment of endotoxemic septic shock

March 7 Spectral Medical Inc

* U.S. FDA approves Spectral's third PMA module for its toraymyxin treatment of endotoxemic septic shock

* Spectral Medical Inc - "plan to file our fourth and final module containing clinical data early in Q2 of this year" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐